LT-How Cancer Cells Communicate_990x120-2

Event Overview

After a period of uncontrolled proliferation, subsets of primary tumor cells undergo functional phenotypic changes that increase migration and drive metastasis. This webinar sponsored by IsoPlexis will discuss how a unique synergistic paracrine signaling pathway promotes cell migration and causes cancer cells to break away from a tumor and spread throughout the body. Denis Wirtz will highlight how discovering metastasis initiators by cytokine profiling helped researchers develop a potential therapy that inhibits metastasis and improves cancer patient outcomes.

Topics to be covered
  • How cell density and proliferation affect tumor cell metastasis and how they shape the development of novel therapies
  • How cytokine profiling and highly multiplexed proteomic analysis of three-dimensional models help identify proteins encouraging cell migration
  • How identifying a potential mechanism promoting tumor cell migration enables the development of a strategy to decrease tumor cell metastatic capacity
Monday, April 27, 2020
 
1:00 - 2:00 PM, Eastern Standard Time


Speakers

Wirtz.png
Denis Wirtz, PhD
Vice Provost for Research
TH Smoot Professor, Chemical and Biomolecular Engineering, Pathology, Oncology
Director, Johns Hopkins Physical Sciences-Oncology Center
Johns Hopkins University and Johns Hopkins School of Medicine

Chen.png
Jonathan Chen
Technology Co-Inventor
IsoPlexis


IsoPlexis.png

Register Now

How Cancer Cells Communicate and How This Understanding May Stop Cancer’s Ability to Spread

You must have Javascript and Cookies enabled to access this webcast.

Information you provide will be held in confidence and will be shared with the sponsoring vendor(s) of this webinar. We may use the information to contact you about your account and to let you know about related programs and products; you may opt-out at any time. This allows The Scientist to keep these webinars free of charge for our readers.